Species Difference in Intestinal Absorption Mechanism of Etoposide and Digoxin between Cynomolgus Monkey and Rat
Author(s) -
Tomohiro Nishimura,
Yukio Kato,
Naoko Amano,
Midori Ono,
Yoshiyuki Kubo,
Yuka Kimura,
Hisashi Fujita,
Akira Tsuji
Publication year - 2008
Publication title -
pharmaceutical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.815
H-Index - 206
eISSN - 1573-904X
pISSN - 0724-8741
DOI - 10.1007/s11095-008-9658-4
Subject(s) - bioavailability , etoposide , pharmacokinetics , pharmacology , p glycoprotein , intestinal permeability , digoxin , efflux , small intestine , chemistry , ussing chamber , endocrinology , biology , medicine , secretion , biochemistry , chemotherapy , heart failure , multiple drug resistance , antibiotics
The oral bioavailability of some therapeutic agents is markedly lower in cynomolgus monkeys than in humans. We investigated small-intestinal absorption of the P-glycoprotein (P-gp) substrates etoposide and digoxin in monkeys to clarify the influence of efflux transport on their intestinal permeability.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom